Personalized Medicine is a peer-reviewed journal presenting reviews and reports by scientists and decision-makers most closely involved in this rapidly developing area. Personalized Medicine aims at being an essential resource for keeping abreast of the latest developments in all areas of this exciting new field, and focuses on those aspects of most direct relevance to the pharmaceutical industry and wider clinical community.
PharmaNutrition is the truly multidisciplinary home for preclinical and clinical researchers in academia and industry, working at or close to the interface of nutritional and pharmacological treatment concepts: where “nutrition” (food, food ingredients, specialized enteral and parenteral nutrition) and “pharma” (pharmacological intervention, clinical studies) meet, including the combination of the two.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Pharmaceutical Biology will publish manuscripts describing the discovery, methods for discovery, description, analysis characterization, and production/isolation (including sources and surveys) of biologically-active chemicals or other substances, drugs, pharmaceutical products, or preparations utilized in systems of traditional medicine.Topics may generally encompass any facet of natural product research related to pharmaceutical biology. Papers dealing with agents or topics related to natural product drugs are also appropriate (e.g., semi-synthetic derivatives). Manuscripts will be published as reviews, perspectives, regular research articles, and short communications. The primary criteria for acceptance and publication are scientific rigor and potential to advance the field.Read More: http://informahealthcare.com/page/phb/Description.
More than 40 years in publication through 2007, the monthly Pharmaceutical Chemistry Journal is devoted to scientific and technical research on the creation of new drugs and the improvement of manufacturing technology of drugs and intermediates. International contributors cover the entire spectrum of new drug research, including methods of synthesis; results of pharmacological, toxicological, and biochemical studies; investigation of structure - activity relationships in prediction of new compounds; methods and technical facilities used; and problems associated with the development of ecologically safe and economically feasible methods of industrial production. In addition, analytical reviews of international literature in the field report on recent developments around the world. Pharmaceutical Chemistry Journal is a translation of the peer-reviewed Russian journal Khimiko-Farmatsevticheskii Zhurnal.
Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, presents papers which describe innovative research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published here. Current emphasis of the journal includes the following areas: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others. Pharmaceutical Research publishes twelve issues a year.
Pharmaceutical Statistics is an industry-led initiative, tackling real problems in statistical applications. The Journal publishes papers that share experiences in the practical application of statistics within the pharmaceutical industry. It covers all aspects of pharmaceutical statistical applications from discovery, through pre-clinical development, clinical development, post-marketing surveillance, consumer health, production, epidemiology, and health economics. The Journal is both international and multidisciplinary. It includes high quality practical papers, case studies and review papers. The aims of the Journal are to:
Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by scientists and decision-makers most closely involved in this rapidly developing area. Pharmacogenomics aims at being an essential resource for keeping abreast of the latest developments in all areas of this exciting new field, and focuses on those aspects of most direct relevance to the pharmaceutical industry and wider clinical community.
The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.Key areas of coverage include: * Personalized medicine * Effects of genetic variability on drug toxicity and efficacy * Identification and functional characterization of polymorphisms relevant to drug action * Pharmacodynamic and pharmacokinetic variations and drug efficacy * Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics * Clinical applications of genomic science * Identification of novel genomic targets for drug development * Potential benefits of pharmacogenomics.
Journal of Lie Theory is a journal for speedy publication of information in the following areas: Lie algebras, Lie groups, algebraic groups, and related types of topological groups such as locally compact and compact groups. Applications to representation theory, differential geometry, geometric control theory, theoretical physics, quantum groups are considered as well. The principal subject matter areas according to the Mathematics Subject Classification are 14Lxx, 17Bxx, 22Bxx, 22Cxx, 22Dxx, 22Exx, 53Cxx, 81Rxx.
Pharmacological Research provides a rapid information exchange medium for specialists within the discipline of pharmacology. The journal publishes papers on basic and applied pharmacological research and is proud of its rapid publication of accepted papers.Invited and unsolicited review articles are also featured.Research Areas are:• Biochemical and molecular pharmacology• Cardiovascular pharmacology• Gastrointestinal pharmacology• Clinical pharmacology, if addressing novel mechanisms of action• Respiratory tract pharmacology• Urogenital tract pharmacology• Pharmacology of tissue repair• Neuropharmacology, psychopharmacology, and neuroendocrinology• Chemotherapy and cancer therapy• Immunopharmacology• Pharmacological applications of genomics• Pharmacology of aging• Nutraceuticals, if relevant to human diseaseNote that ethnopharmacological studies generally do not fall into the scope of this journal. Exceptions are made for papers addressing the mechanisms of actions or the clinical applications of worldwide-used natural substances. Clinical studies on commercially-available nutraceuticals are also taken into consideration.Immediate rejection criteria are:1. Ethnopharmacological papers, namely studies that deal with locally-consumed plants.2. In vitro antioxidant activity of plant extracts and pure compounds isolated from them.3. Papers that describe pharmacological activities of plants which are not easily found worldwide, eg, Chinese herbs.4. Papers reporting pharmacological activities of novel compounds if no proper controls with known substances are performed.5. Papers describing the pharmacological activities of natural compounds are considered only if they identify novel mechanisms of action. In particular, Pharmacol Research does not publish papers that describe• Single dose studies with very few animals, no dose-response studies.• In-vitro assays with single dose or very high dose, measuring only one endpoint.• Repetition of a simple bioassay for yet another extract or plant.
This quarterly journal showcases important review articles on topics of high current interest. Topics covered have included biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology, clinical pharmacology, and toxicology. IUPHAR nomenclature reports are published here.
Pharmacology is an international journal committed to sharing the latest findings, news, and concepts pertaining to drug discovery, development, and therapy. Original scientific research presented in this journal stretches from basic to clinical studies, mirroring the scope which spans from bench-to-bedside research to modern reverse translational studies and precision medicine approaches. The journal primarily publishes research articles, reviews and commentaries to encourage knowledge transfer and discussion among the audience with an interest in experimental and clinical pharmacology, toxicology, pharmaceutical medicine, and biomedical sciences.
Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely behavioral studies and toxicology studies will not be published unless they have directly demonstrable relevance to the areas of pharmacology or biochemistry. Papers describing the behavioral effects of novel psychoactive drugs in models of psychiatric diseases must include a positive control.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com